Catalyst Wire Dossier Catalyst Wire Dossier

HETLIOZ LQ

tasimelteon · Vanda Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HETLIOZ LQ, covering 2020-12-01 to 2020-12-01. Get the full timeline:

Most recent: FDA Approved: HETLIOZ LQ — Original Application (Vanda Pharmaceuticals Inc.)

See pricing